Sudden hearing loss after intravitreal aflibercept injection

Abstract

Intravitreal (IV) application of antiangiogenic drugs is an invasive procedure that requires following a safety protocol during application. Ocular side effects of anti-VEGF agents, such as subconjunctival hemorrhage, intraocular pressure elevation, vitreous hemorrhage, retinal detachment, and endophthalmitis, were addressed in a previous study(1)